Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Takimoto

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Problems in Cancer|June 16, 2001
The clinical pharmacology of the oral fluoropyrimidinesC H Takimoto
Seminars in Oncology|January 7, 1998
Antifolates in clinical developmentC H Takimoto
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Why drugs fail: of mice and men revisitedC H Takimoto
Journal of the National Cancer Institute|April 5, 1995
Enigma of fluorouracil and levamisoleC H Takimoto
Cancer Treatment and Research|February 28, 2001
Basic pharmacokinetics and pharmacodynamic principlesC H Takimoto
The New England Journal of Medicine|August 6, 1992
Cancer in the contralateral breast after radiotherapy for breast cancerC H Takimoto
Annals of the New York Academy of Sciences|February 24, 2001
The clinical development of 9-aminocamptothecinC H Takimoto, R Thomas
Seminars in Hematology|October 21, 1998
An overview of topoisomerase I-targeting agentsS G Arbuck, C H Takimoto
Oncology (Williston Park, N.Y.)|December 12, 1997
Clinical status and optimal use of topotecanC H Takimoto, S G Arbuck
Oncology (Williston Park, N.Y.)|July 1, 1995
New antifolates in clinical developmentC H Takimoto, C J Allegra
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Problems in Cancer|June 16, 2001
The clinical pharmacology of the oral fluoropyrimidinesC H Takimoto
Seminars in Oncology|January 7, 1998
Antifolates in clinical developmentC H Takimoto
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Why drugs fail: of mice and men revisitedC H Takimoto
Journal of the National Cancer Institute|April 5, 1995
Enigma of fluorouracil and levamisoleC H Takimoto
Cancer Treatment and Research|February 28, 2001
Basic pharmacokinetics and pharmacodynamic principlesC H Takimoto
The New England Journal of Medicine|August 6, 1992
Cancer in the contralateral breast after radiotherapy for breast cancerC H Takimoto
Annals of the New York Academy of Sciences|February 24, 2001
The clinical development of 9-aminocamptothecinC H Takimoto, R Thomas
Seminars in Hematology|October 21, 1998
An overview of topoisomerase I-targeting agentsS G Arbuck, C H Takimoto
Oncology (Williston Park, N.Y.)|December 12, 1997
Clinical status and optimal use of topotecanC H Takimoto, S G Arbuck
Oncology (Williston Park, N.Y.)|July 1, 1995
New antifolates in clinical developmentC H Takimoto, C J Allegra
Pageof 6